Inhalationally Administered Semifluorinated Alkanes (SFAs) as Drug Carriers in an Experimental Model of Acute Respiratory Distress Syndrome

Aerosol therapy in patients suffering from acute respiratory distress syndrome (ARDS) has so far failed in improving patients’ outcomes. This might be because dependent lung areas cannot be reached by conventional aerosols. Due to their physicochemical properties, semifluorinated alkanes (SFAs) coul...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmaceutics
Main Authors: Otto, Matthias, Krebs, Jörg, Welker, Peter, Holm, René, Thiel, Manfred, Gattinoni, Luciano, Quintel, Michael, Tsagogiorgas, Charalambos
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8004724/
https://ncbi.nlm.nih.gov/pubmed/33806903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13030431
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados